Key Dates


Abstracts Due: 12/31/2020

Decisions Sent Out: 01/07/2021 

Connect Science Seminar Series

Virtual Symposium | DF/HCC Celebration of Early Career Investigators in Cancer Research

Early career investigators are a unique reservoir of new ideas, innovation, and excellence in cancer research. To celebrate this, we welcome you to join the 8th Annual DF/HCC Celebration of Early Investigators in Cancer Research. This symposium will showcase the talent of early career investigators at the Dana-Farber/Harvard Cancer Center (DF/HCC) who work in several areas of population science, including epidemiology, biostatistics, outcomes, diversity, and survivorship. We invite all members of the public to attend the event. We also invite students, post-docs, residents, clinical fellows, and early career investigators to submit abstracts for consideration as oral or poster presentations. We look forward to an exciting afternoon of discussion, sharing new discoveries, and building new collaborations. – Lorelei Mucci, ScD (HSPH), Meir Stampfer, MD, DrPH (BWH), Giovanni Parmigiani, PhD (DFCI), Erica Feick (DFCI) and Bailey Vaselkiv (HSPH).

2021 Agenda

January 21, 2021


Watch the recorded videos – Part 1 and Part 2

1:00 - 1:05 pm Introduction 
1:05 - 1:30 pm

Keynote Speaker:

Brian Wolpin, MD, MPH
Director, Gastrointestinal Cancer Center at Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School 

Talk Title: "Multidisciplinary research to advance the care of patients with gastrointestinal cancers"

Biography:
Dr. Wolpin received his medical degree from Harvard Medical School in 2001. He subsequently completed his residency in Internal Medicine at Brigham and Women's Hospital, and his fellowship in Medical Oncology at the Dana-Farber Cancer Institute.

He joined the staff of DFCI and Brigham and Women's Hospital in 2007, where he is a medical oncologist and clinical investigator in the Center for Gastrointestinal Oncology. His research focuses on biomarkers and novel therapeutics in gastrointestinal malignancies, with a particular focus on pancreatic cancer.
1:30 - 2:00 pm

Panel Discussion
Charlie Fuchs, Sapna Syngal. Matt Vander Heiden, and Kimmie Ng
2:00 - 2:45 pm Oral Presentations - Hide Presenters
  • Jan Heng: Deep Learning Image Analysis of Benign Breast Disease to Identify Subsequent Risk of Breast Cancer
  • Bryan Iorgulescu: Underutilization of Guideline-Recommended Mismatch Repair/Microsatellite Instability Biomarker Testing in Patients with Advanced Colorectal Cancer
  • Jane Liang: Aggregating across genes and cancers in Mendelian risk prediction modeling
  • David-Dan Nguyen: Impact of the COVID-19 pandemic on the delivery of Definitive Therapy for Cancer at Mass General Brigham
  • Naoko Sasamoto: Personalized cutpoints of CA125 to improve early detection of ovarian cancer in postmenopausal women
  • Konrad Stopsack: Batch effects in tumor biomarker studies using tissue microarrays: Extent, impact, and remediation
  • Oana Zeleznik: Circulating amino acids and amino acid-related metabolites and risk of breast cancer among predominantly premenopausal women
2:45 - 3:30 pm

Poster Session - Hide Presenters
3:30 pm Award Announcement